Concise Prescribing Info
Listed in Dosage.
Dosage/Direction for Use
Adult: Ophth Production of mydriasis As 0.5% soln: Instill 1-2 drops 15-20 mins before examination. Production of cycloplegia As 1% soln: Instill 1-2 drops, repeated after 5 mins. May instill another drop after 20-30 mins for prolonged effect.
Hypersensitivity. Narrow-angle glaucoma or shallow anterior chamber.
Special Precautions
Elderly, children, pregnancy. Hypertension, hyperthyroidism, DM, cardiac disorders. To reduce systemic absorption, press on the lacrimal sac for 1-2 minutes following instillation. Do not drive or engage in hazardous activities and protect eyes from bright illumination when pupils are dilated. May fail to produce adequate cycloplegia in children.
Adverse Reactions
Increased intraocular pressure, transient stinging, dry mouth, blurred vision, photophobia, tachycardia, headache, superficial punctate keratitis, systemic anticholinergic effects, severe CNS disturbances in children (rare).
Drug Interactions
May antagonise effects of ophthalmic carbachol, pilocarpine, or cholinesterase inhibitors.
CIMS Class
ATC Classification
S01FA06 - tropicamide ; Belongs to the class of anticholinergics used as mydriatics and cycloplegics.
Disclaimer: This information is independently developed by CIMS based on tropicamide from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in